GB1290141A - - Google Patents

Info

Publication number
GB1290141A
GB1290141A GB1290141DA GB1290141A GB 1290141 A GB1290141 A GB 1290141A GB 1290141D A GB1290141D A GB 1290141DA GB 1290141 A GB1290141 A GB 1290141A
Authority
GB
United Kingdom
Prior art keywords
vaccines
toxoid
welchii
polyornithine
polyarginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1290141A publication Critical patent/GB1290141A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1290141 Vaccines WELLCOME FOUNDATION Ltd 29 Aug 1969 [31 May 1968] 26115/ 68 Heading A5B [Also in Divisions C2 and C3] Vaccines comprise a non-pathogenic antigenic material and, as adjuvant, a base-rich peptide in which at least 50% of the residues have free amino groups. Examples thereof include polylysine, polyornithine, polyarginine and polydiaminobutyric acid. Antigenic materials referred to include diphtheria toxoid, tetanus toxoid, calf pneumonia virus and Cl. welchii epsilon toxoid. Reference is also made to various viral, bacterial and protozoal vaccines.
GB1290141D 1968-05-31 1968-05-31 Expired GB1290141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2611568 1968-05-31

Publications (1)

Publication Number Publication Date
GB1290141A true GB1290141A (en) 1972-09-20

Family

ID=10238613

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1290141D Expired GB1290141A (en) 1968-05-31 1968-05-31

Country Status (1)

Country Link
GB (1) GB1290141A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038153A2 (en) * 1980-04-15 1981-10-21 Beecham Group Plc Modified allergens
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION
DE19638313A1 (en) * 1996-09-19 1998-04-02 Boehringer Ingelheim Int Composition containing immunomodulatory peptide or protein and adjuvant
WO2000056361A2 (en) * 1999-03-24 2000-09-28 The Secretary Of State For Defence Vaccine composition
US6166217A (en) * 1998-02-09 2000-12-26 Alliedsignal Inc. Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
AT408721B (en) * 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIG
WO2002053185A2 (en) * 2001-01-05 2002-07-11 Intercell Ag Anti-inflammatory use of polycationic compounds
US7105162B1 (en) 1996-02-24 2006-09-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition for immunomodulation based on peptides and adjuvants
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
US20170014350A1 (en) * 2015-07-16 2017-01-19 University-Industry Foundation, Yonsei University Oral virus vaccine

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
EP0038153A2 (en) * 1980-04-15 1981-10-21 Beecham Group Plc Modified allergens
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION
US7105162B1 (en) 1996-02-24 2006-09-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition for immunomodulation based on peptides and adjuvants
DE19638313A1 (en) * 1996-09-19 1998-04-02 Boehringer Ingelheim Int Composition containing immunomodulatory peptide or protein and adjuvant
DE19638313C2 (en) * 1996-09-19 2000-05-31 Boehringer Ingelheim Int Pharmaceutical composition for immunomodulation
US6166217A (en) * 1998-02-09 2000-12-26 Alliedsignal Inc. Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
AU762078B2 (en) * 1999-03-24 2003-06-19 Secretary Of State For Defence, The Vaccine composition
WO2000056361A2 (en) * 1999-03-24 2000-09-28 The Secretary Of State For Defence Vaccine composition
WO2000056361A3 (en) * 1999-03-24 2001-03-01 Secr Defence Vaccine composition
EP2269640A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
EP2269642A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
AT408721B (en) * 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIG
EP2269643A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
EP2269641A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
US8277815B2 (en) 1999-10-01 2012-10-02 Intercell Ag Pharmaceutical composition comprising an antigen
WO2002053185A3 (en) * 2001-01-05 2002-10-31 Intercell Biomedizinische Forschungs & Entwicklungs Gmbh Anti-inflammatory use of polycationic compounds
WO2002053185A2 (en) * 2001-01-05 2002-07-11 Intercell Ag Anti-inflammatory use of polycationic compounds
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
US20170014350A1 (en) * 2015-07-16 2017-01-19 University-Industry Foundation, Yonsei University Oral virus vaccine
US10136662B2 (en) * 2015-07-16 2018-11-27 University-Industry Foundation, Yonsei University Oral virus vaccine

Similar Documents

Publication Publication Date Title
GB1290141A (en)
GB1502774A (en) Immunological preparations
ES8202584A1 (en) Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer.
ES465514A1 (en) Glucosamine derivatives and a process for their manufacture
LU91154I2 (en) Combination of diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous hemagglutinin, pertactin, type 1, type 2 and type 3 inactivated polio virus and Haemophilus influenzae type b capsular polysaccharide.
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
HUP9904287A1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids
GB1422973A (en) Process for preparing adsorbed vaccines
GB1059676A (en) Process for stabilising biologically active proteinaceous materials
ES475509A1 (en) Pneumococcal vaccine and a process for its preparation.
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
GB1292803A (en) Improvements relating to the production of antigens
JPS5527178A (en) Live influenza virus vaccine
GB1413614A (en) Virus production
GB1488800A (en) Influenza vaccines
EP0270295A3 (en) Conjugate vaccine
OA09863A (en) Use of IL-4 to enhance immune response to immunogens in vaccines.
GB1399782A (en) Vaccines for immunization against kennel cough
CA980251A (en) Adjuvants for vaccines and vaccine preparations containing them
ES8107300A1 (en) Herpes virus vaccine and its preparation.
GB1436323A (en) Cell and virus culture systems
GB1212886A (en) Equine vaccine and vaccination treatment
GB1439742A (en) Live influenza type b virus vaccines and preparation thereof
EP0186368A3 (en) Biological preparations
GR3020495T3 (en) Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee